Leonard M. Greenstein - 22 Jul 2025 Form 3 Insider Report for CARLSMED, INC.

Role
CFO, Treasurer
Signature
/s/ Leonard Greenstein
Issuer symbol
CARL on Nasdaq
Transactions as of
22 Jul 2025
Net transactions value
$0
Form type
3
Filing time
22 Jul 2025, 17:31:15 UTC
Previous filing
21 Apr 2023
Next filing
30 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Greenstein Leonard M. CFO, Treasurer C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD /s/ Leonard Greenstein 22 Jul 2025 0001519692

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CARL Common Stock 143,369 22 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CARL Stock Option (Right to Buy) 22 Jul 2025 Common Stock 83,673 $1.17 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock are reported after giving effect to the 1-to-5.58 reverse split of the Issuer's common and preferred stock, effected on July 10, 2025 (the "Reverse Split").
F2 These options are reported after giving effect to the Reverse Split of the Issuer's common stock.
F3 Includes 83,673 stock options convertible into approximately 83,673 shares of the Issuer's common stock, which began to vest on August 14, 2023. 40,093 of these stock options are fully vested and exercisable stock options convertible into approximately 40,093 shares of the Issuer's common stock and 43,580 are unvested stock options convertible into approximately 43,580 shares of the Issuer's common stock and will be fully vested on August 14, 2027.
F4 The exercise price has been adjusted to reflect the Reverse Split.